Optimization of Surgical Treatment of Patients With Incisional Ventral Hernias
Launched by SAMARA STATE MEDICAL UNIVERSITY · Feb 8, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the surgical treatment of patients with incisional ventral hernias, which are bulges that can occur in the abdominal wall after previous surgeries. The researchers are exploring new surgical techniques that aim to enhance patient recovery and reduce complications during and after surgery. Specifically, they want to understand the anatomy of the area where the surgery will take place and develop methods that cause less damage to important blood vessels and nerves. By comparing a new technique with standard surgery methods, they hope to find out if the new approach leads to better outcomes for patients.
To participate in this study, individuals must have a specific type of postoperative ventral hernia that is medium to large in size (between 4.1 cm and 15 cm wide). The trial is open to both men and women, and they are currently looking for volunteers. If you join, you can expect to undergo a surgical procedure and be monitored closely to see how well you recover. This research could help improve future treatments for hernias, making surgeries safer and more effective for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The study will include patients with postoperative ventral hernias of median and lateral localization and an average hernial gate width from 4.1 to 15 cm (W2-W3 according to the EHS classification).. The size of the hernial gate is determined by CT.
- Exclusion Criteria:
- • Patients without postoperative ventral hernias median and lateral localization
About Samara State Medical University
Samara State Medical University is a distinguished institution dedicated to advancing medical education, research, and healthcare innovation. With a commitment to excellence, the university plays a pivotal role in clinical research, fostering collaborations that enhance patient care and contribute to the scientific community. Its state-of-the-art facilities and a team of experienced professionals ensure the highest standards in clinical trial management and execution, making it a trusted sponsor for studies aimed at improving health outcomes and addressing pressing medical challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Samara, , Russian Federation
Patients applied
Trial Officials
Vladislav Timoschuk, Phd Student
Principal Investigator
Samara State Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials